COVID-19 and the liver

EASL and the WHO have combined to create their first joint webinar on COVID-19 and the liver, broadcast on 14 May 2020. A panel of leading international experts in hepatology and virology reviewed the latest information on the COVID-19 pandemic, the WHO response, and the impact on the care of people with liver disease and viral hepatitis, bo...

Webcast – Viral testing and the immune response to COVID-19 Following up on their last conversation for the EASL COVID-19 webcast series, Professor Mario Mondelli and Professor Jean-Michel Pawlotsky explore how RNA and antibody tests can be combined with different testing strategies to arrive at potential exit strategies from the social res...

Webcast – Viral markers and the diagnosis of COVID-19 Join Professor Mario Mondelli and Professor Jean-Michel Pawlotsky for a two-part discussion on viral markers in COVID-19 and how they relate to diagnosis and public health.

Webcast – Virological Aspects of COVID-19 In this first edition of EASL’s webcast series on COVID-19, Professor Darius Moradpour will take you through the fundamentals of SARS-CoV-2, the cause of COVID-19, supported by two world-renowned virologists. The experts will summarise its structure and genome, piecing together what we know of the e...

Webcast - Obesity and fatty liver disease This episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the virus on patients with obesity and fatty liver disease. The panel of experts comprises Professor Sven Francque, Professor Nalu Navarro-Alvarez, Professor Luca Busetto and Professor Carolyn Bramante.

Webcast - Viral hepatitis elimination This latest episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the pandemic on European efforts to eliminate hepatitis as a public health threat by 2030. Professor Antonio Craxi is joined by Professor Mark Thursz, Professor Jeffrey Lazarus, Dr Loreta Kondili and Sarah Blac...

Ask EASL is an ongoing series of educational podcasts dedicated to answering questions from patients and patient organisations on important topics around liver disease.